Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Asymchem Laboratories Tianjin (002821 CH)
Watchlist
101
Analysis
Health Care
•
China
Asymchem Laboratories (Tianjin) Co., Ltd. operates as a pharmaceutical company. The Company researches, produces, and sells organic and inorganic chemicals, medicines, and other related products. Asymchem Laboratories serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Asymchem Laboratories Tianjin
•
30 Nov 2021 12:08
Asymchem Labs A/H Listing - Pricing Seems Adequate Despite the Share Price Run Up
Asymchem Laboratories (AL) aims to raise up to US$968m in its H-share listing in Hong Kong. In this note, we will talk about the IPO pricing.
Sumeet Singh
Follow
459 Views
Share
bullish
•
China Tourism Group Duty Free Corp Ltd
•
28 Nov 2021 08:44
ECM Weekly (28st Nov 2021) - Weibo HK, China Tourism HK, SenseTime, Gushengtang, Digital Core REIT
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
534 Views
Share
bullish
•
China Tourism Group Duty Free Corp Ltd
•
24 Nov 2021 15:45
China Tourism Group A/H Listing - Recent Updates and a Quick Look at Valuations
China Tourism Group Duty Free Corporation Limited (CDF) aims to raise around US$5bn in its H-share listing in Hong Kong. In this note we talk about...
Sumeet Singh
Follow
417 Views
Share
bullish
•
Asymchem Laboratories Tianjin
•
23 Nov 2021 23:16
Asymchem Laboratories H Share Listing: On-Demand Science
Asymchem is pre-marketing an H Share listing to raise $1.5 billion, according to press reports. The forward indicators suggest that the near-term...
Arun George
Follow
408 Views
Share
bullish
•
Weilong Delicious
•
21 Nov 2021 09:52
ECM Weekly (21st Nov 2021) - Weilong, Cloud Village, SF Intra, China Tourism, Asymchem, Gushengtang
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
588 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x